Target intelligence / Profile preview

Prion Protein Expression Inhibitor

Molecular classification
Other
01

Overview

A prion protein expression inhibitor is a molecule or agent that reduces the synthesis or accumulation of the cellular prion protein (PrP^C), which is encoded by the PRNP gene. The misfolding and aggregation of PrP^C into its pathogenic form (PrP^Sc) underlies prion diseases, a group of fatal neurodegenerative disorders including Creutzfeldt–Jakob disease (CJD) and scrapie. Inhibiting prion protein expression or its pathological conversion is considered a promising therapeutic strategy for these diseases.

02

Mechanism of action

Transcriptional repression, destabilization/folding inhibition, endocytosis/degradation of PrP^C

03

Biological functions

Inhibition of protein expressionNeuroprotection (potential)
04

Disease associations

Neurodegenerative diseaseTransmissible spongiform encephalopathies
05

Safety considerations

Insufficient brain penetration for some compoundsLack of clinical efficacy despite in vitro activityPotential off-target effects of inhibitors
06

Interacting drugs

Quinacrine

5 more in the full profile.

Beyond the preview

Go deeper on Prion Protein Expression Inhibitor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prion Protein Expression Inhibitor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call